← Home UAE · nd-uae

SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

Source: en_prnasisa · 2026-10-08T07:30:00 UTC

BOSTON, Oct. 8, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support precision oncology approaches with AstraZeneca (LSE/STO/NYSE: AZN). PrGIS is a novel biomarker signature designed to assess chromosomal instability associated with

Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.

Read full story on publisher site →

SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

Related in UAE

Rockefeller Foundation Brings AsiaXchange 2026 to Bangkok to Build the Shared Future Through International Cooperation

Wellysis Secures FDA 510(k) Clearance for AI-Powered ECG Analysis Software, S-Patch CardioAI

Mohamed Ramadan goes bold for his Ramadan 2027 series 'Ashmawy'

Making e-scooters safe requires more than fines and enforcement

Wall St set to open lower as oil jump, high yields fuel inflation concerns

Gaza still has no hospital operating at full capacity: Israeli rights group